Table 5.
Multivariable analysis for cardiovascular disease medications change in % items correct in knowledge questionnaire*
| n | Preknowledge score Mean (95% CI) |
Postknowledge score Mean (95% CI) |
B (95% CI) | P value | |
| Statin | |||||
| Session 1 | 160 | 37.4 (34.3 to 40.9) | 87.8 (84.9 to 90.9) | 3.50 (3.06 to 3.01) | <0.001 |
| Session 2 | 155 | 84.0 (80.5 to 87.7) | 94.9 (92.1 to 97.8) | 1.14 (1.09 to 1.19) | <0.001 |
| Session 3 | 151 | 91.2 (88.8 to 93.7) | 97.5 (96.1 to 98.9) | 1.07 (1.04 to 1.10) | <0.001 |
| Aspirin | |||||
| Session 1 | 140 | 30.7 (28.9 to 32.6) | 92.4 (89.9 to 94.9) | 3.01 (2.83 to 3.20) | <0.001 |
| Session 2 | 134 | 86.5 (83.1 to 90.0) | 96.0 (93.9 to 98.1) | 1.11 (1.07 to 1.15) | <0.001 |
| Session 3 | 129 | 91.3 (88.8 to 93.9) | 98.5 (96.8 to 100) | 1.08 (1.05 to 1.11) | <0.001 |
| ACE inhibitor | |||||
| Session 1 | 106 | 24.5 (21.7 to 27.7) | 84.7 (80.6 to 89.0) | 3.50 (3.06 to 3.91) | <0.001 |
| Session 2 | 102 | 81.6 (77.4 to 86.1) | 93.2 (90.3 to 96.2) | 1.14 (1.09 to 1.19) | <0.001 |
| Session 3 | 95 | 89.5 (86.6 to 92.4) | 95.9 (94.2 to 97.8) | 1.07 (1.04 to 1.10) | <0.001 |
| Beta blocker | |||||
| Session 1 | 104 | 27.9 (24.3 to 32.0) | 84.0 (79.5 to 88.9) | 3.01 (2.60 to 3.49) | <0.001 |
| Session 2 | 101 | 84.6 (80.0 to 89.4) | 94.4 (91.4 to 97.5) | 1.12 (1.07 to 1.16) | <0.001 |
| Session 3 | 97 | 88.8 (85.7 to 92.1) | 97.4 (95.4 to 99.5) | 1.10 (1.06 to 1.13) | <0.001 |
*Model included site and diabetes comorbidity.